Karl Doghramji, MD discusses the importance of differentiating the different types of insomnia, lifestyle management, and the newest class of drugs to treat insomnia
In this episode, Karl Doghramji, MD, Medical Director at the Jefferson Sleep Disorders Center in Philadelphia, talks to clinicians about the newest class of pharmacologic agents, orexin receptor antagonists, for the treatment of insomnia. He also discusses how to recognize signs, symptoms, and risk factors that should trigger screening, differentiation of the different types of sleep disorders, and lifestyle measures that should be part of any treatment.